New Drugs on the Horizon: Matrix Metalloproteinase Inhibitors

Oncologist- United States

doi 10.1634/theoncologist.3-4-271

Full Text

Abstract

Available in

Date

Authors

Publisher

Alphamed Press

Related search

Matrix Metalloproteinase Inhibitors Enhance the Efficacy of Frontline Drugs Against Mycobacterium Tuberculosis

PLoS Pathogens
ImmunologyMolecular BiologyVirologyMicrobiologyParasitologyGenetics
2018English

Matrix Metalloproteinase/Tissue Inhibitors of Matrix Metalloproteinase Phenotype Identifies Poor Prognosis Colorectal Cancers

Clinical Cancer Research
Cancer ResearchOncology
2004English

Triple-Helical Transition State Analogues: A New Class of Selective Matrix Metalloproteinase Inhibitors

Journal of the American Chemical Society
BiochemistryColloidCatalysisChemistrySurface Chemistry
2007English

Binding of Matrix Metalloproteinase Inhibitors to Extracellular Matrix: 3d-Qsar Analysis

Chemical Biology and Drug Design
BiochemistryOrganic ChemistryDrug DiscoveryMolecular MedicinePharmacology
2008English

Frontispiece: Design and Structural Evolution of Matrix Metalloproteinase Inhibitors

Chemistry - A European Journal
Organic ChemistryCatalysisChemistry
2019English

Towards Third Generation Matrix Metalloproteinase Inhibitors for Cancer Therapy

British Journal of Cancer
Cancer ResearchOncology
2006English

Structures of Matrix Metalloproteinase - 9 in Complex With Pharmacological Inhibitors

Acta Crystallographica Section A Foundations of Crystallography
2005English

Solid-Phase Synthesis of Succinylhydroxamate Peptides: Functionalized Matrix Metalloproteinase Inhibitors

English

Epilysin (Matrix Metalloproteinase-28) Joins the Matrix Metalloproteinase Team on the Field of Postmyocardial Infarction Remodeling

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy